What Is Purple Biotech Ltd. (PPBT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Purple Biotech Ltd.'s intrinsic value is estimated at a composite fair value of $3.68. While the stock appears modestly undervalued at $1.43 (implied upside of +157.6%), our analysis suggests a thinner margin of safety across 2 of 3 bullish models. Notably, Dynamic NAV sees the most upside at +474.7% (fair value: $8.22), while EROIC is the most conservative at -17.7% ($1.18). The spread between these extremes — +492.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About PPBT?
3 of 13 models are currently active for PPBT. Of these, 2 models suggest upside while 1 model suggests overvaluation. See which stocks rank higher →
How Does PPBT Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, PPBT ranks #350 by Quality of Company score. CirclFi's QOC score of 3.9/10 evaluates 32 fundamental signals. A score of 3.9 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to healthcare company businesses. For Purple Biotech Ltd., metrics like R&D productivity ratio provide important context that general-purpose valuation models may underweight.
Is PPBT a Value Trap?
The Value Trap algorithm is not active for PPBT. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
3 of 13 models are active for Purple Biotech Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Purple Biotech Ltd. scores 3.9 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +492.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every PPBT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across PPBT's 3 active models, average confidence is 7%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad